NRx Pharmaceuticals Inc. (NRXP)
NASDAQ: NRXP
· Real-Time Price · USD
2.88
0.21 (7.87%)
At close: Aug 15, 2025, 3:59 PM
2.87
-0.34%
After-hours: Aug 15, 2025, 07:40 PM EDT
NRx Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4K | 4K | 8K | 8K | 8K | 8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 3K | 4K | 3K | 5K | 5K | 5K | 5K | 4K | 4K | 4K | 3.4K | 3.03K | 3K | 2K | 909.01K | 908.37K | 907.41K |
Gross Profit | 1K | n/a | -3K | -5K | -5K | -5K | -5K | -4K | -4K | -4K | -3.4K | -3.03K | -3K | -2K | -908.61K | -907.97K | -907K |
Operating Income | -16.35M | -18.5M | -20.48M | -23.26M | -24.4M | -27.84M | -33.32M | -36.65M | -38.06M | -44.33M | -87.42M | -98.38M | -105.9M | -115.8M | -107.94M | -92.99M | -75.77M |
Interest Income | 21K | 44K | 114K | 227K | 365K | 494K | 550K | 526K | 404K | 248K | 118K | 23.37K | 475.00 | 475.00 | 475.00 | 107.00 | n/a |
Pretax Income | -24.11M | -25.13M | -20.39M | -24.83M | -25.65M | -30.16M | -36.06M | -39.08M | -37.34M | -39.75M | -60.31M | -88.27M | -81.41M | -93.45M | -107.78M | -75.9M | -75.68M |
Net Income | -24.11M | -25.13M | -20.38M | -24.82M | -25.64M | -30.15M | -36.06M | -39.08M | -37.34M | -39.75M | -60.31M | -88.27M | -81.41M | -93.45M | -107.78M | -75.9M | -75.68M |
Selling & General & Admin | 12.2M | 13.51M | 12.78M | 12.86M | 12.68M | 14.21M | 17.78M | 20.29M | 22.87M | 27.31M | 68.44M | 77.25M | 83.07M | 74.94M | 34.92M | 24.85M | 12.92M |
Research & Development | 5.25M | 6.2M | 7.7M | 10.4M | 11.47M | 13.37M | 15.29M | 16.11M | 15.19M | 17.03M | 18.98M | 21.13M | 22.83M | 20.26M | 18.14M | 16.2M | 12.93M |
Other Expenses | -1.1M | -1.2M | n/a | n/a | 250K | 250K | 250K | 250K | n/a | n/a | 603.00 | 603.00 | 603.00 | 236.18K | 4.16M | 1.23M | -792.42K |
Operating Expenses | 16.35M | 18.5M | 20.47M | 23.26M | 24.4M | 27.84M | 33.32M | 36.65M | 38.06M | 44.33M | 87.42M | 98.38M | 105.9M | 94.43M | 86.58M | 71.63M | 54.41M |
Interest Expense | n/a | 230K | 310K | 350K | 350K | 120K | 40K | n/a | n/a | 3K | 5.34K | 10.71K | 15.82K | 17.82K | 20.16K | 27.3K | 24.73K |
Selling & Marketing Expenses | 1K | n/a | -2K | -2K | -2K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.35M | 18.5M | 20.48M | 23.26M | 24.4M | 27.84M | 33.32M | 36.65M | 38.06M | 44.33M | 87.42M | 98.38M | 105.9M | 115.68M | 107.82M | 92.87M | 75.65M |
Income Tax Expense | n/a | -42.28K | -1.44M | -1.4M | -1.4M | -1.35M | 40K | -58K | -58K | -58K | -58K | 5.37K | 5.37K | -21.36M | -21.36M | -21.41M | -21.41M |
Shares Outstanding (Basic) | 16.41M | 10.52M | 10.97M | 10.52M | 8.85M | 83.92M | 8.2M | 73.22M | 67.45M | 66.45M | 64.88M | 65.73M | 63.67M | 51.74M | 54.81M | 41.73M | 3.57M |
Shares Outstanding (Diluted) | 16.41M | 10.52M | 10.97M | 10.52M | 8.85M | 83.92M | 8.2M | 73.22M | 67.45M | 66.45M | 66.45M | 65.73M | 63.67M | 51.74M | 54.81M | 42.49M | 35.66M |
EPS (Basic) | -2.1 | -2.5 | -1.69 | -2.28 | -1.65 | -1.1 | -1.14 | -0.54 | -0.48 | -0.47 | -0.99 | -1.23 | -62.46 | -62.99 | -79.12 | -78.88 | -17.58 |
EPS (Diluted) | -2.1 | -2.5 | -1.69 | -2.28 | -1.65 | -1.1 | -1.14 | -0.54 | -0.48 | -2.39 | -2.91 | -3.15 | -67.38 | -72.38 | -88.51 | -88.27 | -23.97 |
EBITDA | -24.11M | -24.89M | -20.07M | -24.46M | -25.28M | -30.02M | -36.01M | -39.08M | -37.34M | -39.75M | -60.3M | -88.26M | -81.39M | -93.43M | -107.76M | -75.87M | -75.65M |
EBIT | -24.11M | -24.9M | -20.07M | -24.47M | -25.29M | -30.03M | -36.02M | -39.08M | -37.34M | -39.75M | -60.3M | -88.26M | -81.39M | -93.43M | -107.76M | -75.87M | -75.65M |
Depreciation & Amortization | 4K | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 4K | 4K | 3.4K | 3.03K | 3K | 2K | 2.5K | 2.97K | 2K |